MFDS — authorised 31 December 1993
- Marketing authorisation holder: NOVARTIS
- Status: likely_approved
🇰🇷 Lescol in South Korea
MFDS authorised Lescol on 31 December 1993
Marketing authorisation
Lescol in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Lescol approved in South Korea?
Yes. MFDS authorised it on 31 December 1993.
Who is the marketing authorisation holder for Lescol in South Korea?
NOVARTIS holds the South Korean marketing authorisation.